9:22 AM
Leo Group India
| ||
| Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat ... News-Medical.net Mylan Pharmaceuticals, based in Morgantown, W.Va., gained FDA approval for 15 milligram, 30 mg and 45 mg pioglitazone tablets. "Controlling blood sugar levels is very important in preventing or reducing the long-term health complications of diabetes," ... See all stories on this topic » | ||
| 1.5 lakh sales promotion employees to be on nationwide strike on August 23 Economic Times SILIGURI: Around one and half lakh sales promotion employees through out the whole country are going to observe one day strike on the 23rd August under the banner of Federation of Medical and Sales Representatives Associations of India(FMRAI) with ... See all stories on this topic » | ||
| The pharmaceutical and motorcar trade The Citizen Daily Ditto for pharmaceuticals... Reportedly, at least 30 per cent of the drugs on the market are counterfeit, substandard - or both! That's partly why the sick never fully recover, even as the organisms that cause illness develop resistance to 'medicine ... See all stories on this topic » | ||
| Cinven acquires UK-based Mercury Pharma for £465 million from HgCapital pharmabiz.com Cinven, an European private equity firm, has reached agreement to acquire UK-based specialty pharmaceutical company, Mercury Pharma (Mercury), as a platform for further industry consolidation. The company has been acquired from HgCapital for an ... See all stories on this topic » | ||
| Mylan Launches Generic Actoplus Met® Tablets and Generic Actos® Tablets Sacramento Bee These products are the generic versions of Takeda Pharmaceutical Company's Actos® Tablets and Actoplus Met® Tablets, respectively, and are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. See all stories on this topic » | ||
| Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday ... Sacramento Bee DALLAS and NEW YORK, Aug. 17, 2012 -- /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology and oncology ... See all stories on this topic » | ||
| GMI Ratings Governance Issue | Pharmaceutical Companies Business Insider As regulators call out pharmaceutical companies for misconduct, it seems logical that the people affected will take steps to avoid having such problems again in the future. Which ones will succeed in the coming years remains an open question. See all stories on this topic » | ||
| FDA approves updated prescribing information for… Pharmaceutical Processing 17, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta® ... See all stories on this topic » | ||
| Genus pharmaceuticals told to remove 'sexist' advert DigitalJournal.com A complaint was made about the content of the advert by a medical doctor to a pharmacy body based in the UK, which enforces a code for the advertising of pharmaceutical products (the ABPI, Association of the British Pharmaceutical Industry). The matter ... See all stories on this topic » | ||
| Government will help local investors to start joint ventures in proposed ... The Official Government News Portal of Sri Lanka A delegation from Pharmaceuticals Export Promotion Council of India met Basil Rajapaksa, Senior Adviser to the President and Minister of Economic development to discuses about setting up of a pharmaceuticals hub in Sri Lanka. The meeting was held at ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment